Fortune 500 Drug & Device Development Company Implements SafeBreach for Security Control Validation

A provider of outsourced services to pharmaceutical companies, biotechnology firms, medical device manufacturers, and public health organizations, the Fortune 500 company gathers and manages a significant amount of highly sensitive intelligence that needs to be secured at all times.

While the security team was making significant investments in security controls, they struggled to effectively assess how secure they really were. That’s why they adopted SafeBreach. With the SafeBreach platform, the team can automatically execute attacks safely and continuously—so they can gain the tangible intelligence they need to identify and address their most critical vulnerabilities.

fortune500druganddeviceco_safebreach_case_study